Optimizing iNKT-driven immune responses against cancer by modulating CD1d in tumor and antigen presenting cells is a research paper published in Clinical Immunology (2024). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Science Foundation
Grant: 1912322
Targeted Infusion Project: Transforming Biology Laboratory Learning by the Development, Deployment and Assessment of evidenced-based research and learning (EBRL) experiences
National Institutes of Health
Grant: R25AG070244
American Cancer Society
Grant: DICRIDG-22\u20131037199\u201301
FWCI
1.66
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords